ALICR.PA Gross Margin

As of 2025-07-16, the Gross Margin of ICeram SA (ALICR.PA) is 53.8%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ALICR.PA Gross Margin - Historical Value

Date	Value
2023-12-31	53.8%
2022-12-31	99.3%
2021-12-31	76.7%
2020-12-31	69.3%
2019-12-31	63.7%
2018-12-31	65.7%
2017-12-31	55.6%
2016-12-31	56.9%
2015-12-31	69.3%
2014-09-30	66.7%

ALICR.PA Gross Margin - Peers Comparison

Ticker	Name	Value
ACARIX.ST	Acarix AB	90.2%
ALBIO.PA	Biosynex SA	56.8%
ALBLU.PA	Bluelinea SA	99.3%
ALCAR.PA	Carmat SA	-338.5%
ALCOR.PA	Biocorp Production SA	91.2%
ALEMG.PA	Euromedis Groupe SA	34.3%
ALIMP.PA	Implanet SA	53.1%
ALPIX.PA	Pixium Vision SA	100%
ALSAF.PA	Safe SA	74.4%
ALSPW.PA	Spineway SA	70.7%
ALTER.PA	Theradiag SA	74.2%
ALTHE.PA	Theraclion SA	42.9%
ALVMG.PA	Klea Holding	94.2%
AMPLI.PA	Amplitude Surgical SA	79.4%
ARCOMA.ST	Arcoma AB	39.9%
AWM.WA	Airway Medix SA	-50%
BIM.PA	Biomerieux SA	55.7%
BIOBV.HE	Biohit Oyj	65.3%
DEMG.L	Deltex Medical Group PLC	63.3%
DIGN.ST	Dignitana AB	67.1%
EDAP	Edap Tms SA	41.4%
EOSI.PA	EOS Imaging SA	52.9%
GPXMED.ST	Neola Medical AB	1448.3%
IGPH.SW	IGEA Pharma NV	-22.2%
IRRAS.ST	Irras AB	20.9%
IST.WA	Grupa Modne Zakupy SA	-824.2%
MEDIC.AT	Medicon Hellas SA	74.5%
NANEXA.ST	Nanexa AB	107.1%
NSCI.L	Netscientific PLC	84.8%
NXTMH.HE	Nexstim Oyj	95.9%
PHLOG B.ST	Pharmacolog I Uppsala AB (publ)	65.7%
PLUN.ST	ProstaLund AB	64.6%
SCIB.ST	SciBase Holding AB (publ)	71%
SDOS.ST	ScandiDos AB	46.4%
STNT.PA	Stentys SA	40.6%
SUN.L	Surgical Innovations Group PLC	28.8%